Envestnet Asset Management
ECYT

Envestnet Asset Management’s Endocyte, Inc. Common Stock ECYT Stock Holding History

Envestnet Asset Management’s Portfolio ECYT Stock Details ECYT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-789
Closed -$5K – 2565
2014
Q4 		$5K Sell
789
-88
-10% -$536 ﹤0.01% 2167
2014
Q3 		$5K Hold
877
– – ﹤0.01% 2327
2014
Q2 		$6K Sell
877
-116
-12% -$1.31K ﹤0.01% 2251
2014
Q1 		$24K Hold
993
– – ﹤0.01% 1606
2013
Q4 		$11K Sell
993
-21
-2% -$232 ﹤0.01% 1714
2013
Q3 		$14K Buy
+1,014
New +$16K ﹤0.01% 1589

Other funds holding ECYT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
HCMT
Highland Capital Management (Texas) Dallas, Texas $39M AUM
PA
Pinnacle Associates New York $7.78B AUM 45.07% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
NI
Numeric Investors Boston, Massachusetts $13.7B AUM 28.88% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Envestnet Asset Management's ECYT Position: Q1 2015 in Review

Envestnet Asset Management sold out of Endocyte, Inc. Common Stock (ECYT) in Q1 2015, closing a stake of 789 shares — an estimated $5K sold.

Envestnet Asset Management first reported a position in ECYT in Q3 2013 and held it in 6 quarters. The position peaked at $24K in Q1 2014. 98 funds tracked by Wall St. Rank hold ECYT as of Q1 2015.

  • Envestnet Asset Management reported no remaining Endocyte, Inc. Common Stock position as of Q1 2015 after selling out during the quarter.
  • Envestnet Asset Management sold 789 Endocyte, Inc. Common Stock shares in Q1 2015, an estimated $5K.
  • Envestnet Asset Management first reported a position in Endocyte, Inc. Common Stock in Q3 2013 and held it in 6 quarters.
  • Envestnet Asset Management's Endocyte, Inc. Common Stock position peaked at $24K in Q1 2014.
  • 98 funds tracked by Wall St. Rank held Endocyte, Inc. Common Stock as of Q1 2015.

Based on Envestnet Asset Management's 13F filing for Q1 2015, filed 15 May 2015.